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Abstract 
Objective: A cross-sectional survey involving 134 pulmonary TB patients started on TB treatment at the TB Treatment 
Unit of the regional referral hospital was conducted to ascertain the prevalence of individual and health facility delays 
and associated factors. Prolonged health facility delay was taken as delay of more than 1 week and prolonged patient 
delay as delay of more than 3 weeks. A logistic regression model was done using STATA version 12 to determine the 
delays.
Results: There was a median total delay of 13 weeks and 110 (82.1%) of the respondents had delay of more than 
4 weeks. Patient delay was the most frequent and greatest contributor of total delay and exceeded 3 weeks in 95 
(71.6%) respondents. At multivariate analysis, factors that influenced delay included poor patient knowledge on TB 
(adjOR 6.904, 95% CI 1.648–28.921; p = 0.04) and being unemployed (adjOR 3.947, 95% CI 1.382–11.274; p = 0.010) 
while being female was found protective of delay; adjOR 0.231, 95% CI 0.08–0.67; p = 0.007). Patient delay was the 
most significant, frequent and greatest contributor to total delay, and factors associated with delay included being 
unemployed, low knowledge on TB while being female was found protective of delay.
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Introduction
Tuberculosis (TB) causes devastating effects among mil-
lions of people every year. In 2017, 10 million people 
developed TB disease and an estimated 1.3 million deaths 
among HIV negative TB patients and 300,000 deaths 
among HIV co-infected TB patients were recorded [1].
Uganda is a high HIV/TB prevalent country and just 
like most sub-Saharan countries, TB control has been 
complicated by the high HIV prevalence [2]. Delay in 
presentation, together with delay in making a diagno-
sis and initiation of treatment is responsible for the 
increased morbidity and mortality from TB. This is 
coupled with increased transmission rates in the com-
munity [3]. Prompt diagnosis and early initiation of treat-
ment remain key strategies in TB prevention and control. 
It is thus important that the various types of delays and 
their underlying factors are well studied if the World 
Health Organization (WHO) post 2015 strategy and 
targets are to be realized. This study set out to ascertain 
the prevalence of individual and health facility delays 
and associated factors among pulmonary TB patients at 
Mbale Regional Referral Hospital in Eastern Uganda.
Main text
Methods
A cross sectional survey involving all consenting adult 
patients with pulmonary TB, and started on TB treat-
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unit Uganda in the period September 2015 to February 
2016. Importantly, this facility had benefited from coun-
try wide roll out of GeneXpert technology that started in 
2011.
Clients that had started treatment in the 3 months pre-
ceding or during the study were recruited from the TB 
Unit as they initiated treatment or came back for their 
drug refill. The study excluded clients that were too ill to 
respond. A structured interviewer-administered ques-
tionnaire was used, and this was adapted from a previ-
ous study on TB diagnosis delay in Uganda [4]. Patient 
delay was defined as the time from the onset of a TB 
cardinal symptom (cough lasting more than 2  weeks, 
persistent fevers, noticeable weight loss, excessive night 
sweats) to the first visit to a health care provider (HCP). 
Prolonged patient delay was defined as a period of more 
than 3  weeks. Health facility delay was defined as the 
time taken from first visit to a HCP up to time of TB 
diagnosis. Prolonged health facility delay was defined as 
a delay of more than 1 week. Total delay was taken as the 
sum of patient delay and health facility delay. Treatment 
delay was taken as the duration from when the time the 
diagnosis was made to when the patient was initiated 
on treatment. A family was used to mean people living 
under the same roof.
Data gathered were entered into Epi-data software 
version 2.0.8.56 and exported to Stata software version 
12 for analysis. Bivariate analysis using Fishers test was 
performed on the variables and total delays. Fishers exact 
test was done given the small numbers under the catego-
ries. To ensure more power, we collapsed some categories 
(occupation, education, action taken at consultation and 
second health facility consulted) to be able to perform 
a multivariate analysis of the variables found significant 
using fishers test.
The study was approved by the Institutional Ethics 
Review Boards at International Health Sciences Univer-
sity and Mbale Regional Referral Hospital (IRB approval 
number Number REIRC IN-COM 125/2015).
Results
Social demographic characteristics of the respond-
ents are presented in Table 1. A total of 134 adults were 
enrolled into the study. Of these, 61 (45.5%) were male 
and median age of respondents was 28 years. The median 
family size was 4 with a range of 1–19.
The distribution of delays, individual and health facility 
factors associated with delay analyzed using Fishers test 
and logistical regression are presented in Table 2. Median 
total delay was 13 weeks, with a large total delay of more 
than 4  weeks in 110 (82.1%) respondents. Patient delay 
exceeded 3 weeks in 96 (71.6%) respondents, and median 
patient delay was 11 weeks. Health facility delay exceeded 
1  week in 59 (44.0%) respondents, with median being 
1  week. Treatment delay was witnessed in 74 (58.7%) 
respondents.
At bivariate analysis, factors associated with delay 
were male gender with being female being protec-
tive (p = 0.025), being a professional/technical worker 
(p = 0.001), being married (p = 0.022), low knowledge 
on TB (p = 0.001), having a second consultation from a 
public facility (p = 0.007), poorly equipped health facility 
as judged by patient (p = 0.007) and having only sputum 
examination requested (p = 0.046). At multivariate anal-
ysis, factors that influenced delay included poor patient 
knowledge on TB (p = 0.04) and being unemployed 
(p = 0.010). The median health facility delay was one (1) 
week. Health facility delay was associated with action 
taken at consultation, and when both Xray in addition 
to sputum was done, the number with a delay reduced to 
73.5% (39/53); i.e. a reduction of 16.1%.
Table 1 Socio-demographic and  access characteristics 
of respondents
Characteristic No. patients (%)
Age, mean 32
Sex
 Male 61 (45.5)
 Female 73 (54.5)
Highest education level attained
 University or higher 8 (6.0)
 Primary/middle/secondary 115 (85.8)
 Illiterate 11 (8.2)
Occupation
 Technical/professional 20 (14.9)
 Peasant 69 (51.5)
 Student 29 (21.6)
 Unemployed 16 (12.0)
Marital status
 Married 40 (29.9)
 Single 52 (38.8)
 Divorced/separated 34 (25.4)
 Widowed 8 (5.9)
History of smoking
 Never 98 (73.1)
 Current smoker 1 (0.8)
 Quit smoking 35 (26.1)
Number of household members
 1 10 (7.6)
 > 1 124 (92.4)
Residence
 Urban 58 (43.3)
 Peri-urban 46 (34.3)
 Rural 30 (22.4)
 Homeless/displaced 0 (0)
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Table 2 Distribution of delays and predictors of delay
Total delay n (%) Median
Delay (> 4 weeks) 110 (82.1) 13 weeks
No delay (< 4 weeks) 24 (17.9)
Health facility delay
 Delay (> 1 week) 59 (44.0) 1 week
 No delay (< 1 week) 75 (56.0)
Patient delay
 Delay (> 3 weeks) 96 (71.6) 11 weeks
 No delay (< 3 weeks) 38 (28.4)
Treatment delay
 Delay (> 0 days) 74 (58.7) 1 day
 No delay (0 days) 52 (41.3)
Factors associated with prolonged delay




 Female 65 (89.0) 8 (11.0)
 Male 45 (73.8) 16 (26.2)
Occupation 0.001**
 Technical/professional 20 (100) 0 (0)
 Peasant 58 (84.1) 11 (15.9)
 Student 17 (58.6) 12 (41.4)
 Unemployed (or HW) 15 (93.8) 1 (6.2)
Marital status 0.022**
 Married 37 (92.5) 3 (7.5)
 Single 36 (69.2) 16 (30.8)
 Divorced/separated 30 (88.2) 4 (11.8)
 Widowed 7 (87.5) 1 (12.5)
Household size 0.361
Education level 0.699
 University or higher 6 (75) 2 (25)
 Primary/middle/secondary 94 (81.7) 21 (18.3)
 Illiterate/read and write 10 (90.9) 1 (9.1)
Residence 0.336
 Urban 48 (82.8) 10 (17.2)
 Peri-urban 40 (87.0) 6 (13.0)
 Rural 22 (73.3) 8 (28.7)
Smoking 0.835
 Never 81(82.7) 17 (17.3)
 Current smoker 1 (100) 0 (0)
 Quit smoking 28 (80.0) 7 (20)
Stigma 0.019
Health facility whom you sought consultation: second 0.007**
 TB centre 22 (64.7) 12 (35.3)
 Public hospital/outpatient clinic 66 (89.2) 8 (10.8)
 Private hospital/clinic 19 (90.5) 2 (9.5)
PHC well equipped 0.007**
 Best 53 (73.6) 19 (26.4)
 Worst 57 (91.9) 5 (8.1)
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At multivariate analysis, factors that influenced delay 
included poor patient knowledge on TB (adjOR 6.904, 
95% CI 1.648–28.921; p = 0.04) and being unemployed 
(adjOR 3.947, 95% CI 1.382–11.274; p = 0.010) while 
being female was found protective of delay; adjOR 0.231, 
95% CI 0.08–0.67; p = 0.007).
Discussion
This study done at a regional referral hospital determined 
the magnitude of delay and also the individual and health 
facility factors associated with the delay. A delay of more 
than 4  weeks in 82.1% of the patients was noticed with 
patient delay being the biggest contributor of the total 
delay. A similar study done in Uganda found health facil-
ity delay as the biggest contributor to the delays [3, 4]. 
This difference could be due to improvements in the diag-
nostic capacities of many laboratories especially with the 
introduction of more sensitive tests including the Gen-
eXpert technology could have shortened the health facil-
ity delays. Similar studies in different settings have found 
patient delay as the commonest type of delay [5–7].
Female gender was associated with lower chances of 
having total delay, different from findings in a study 
done in Mukono [8] and other studies [9–12]. The rea-
sons for this could be that the females normally have 
better health seeking behaviors than their male coun-
terparts. Men tend to neglect symptoms until the dis-
ease reaches a serious stage, by which time they tend to 
go directly to public health services without first visit-
ing private health practitioners [13, 14].
Being unemployed in this study was associated with 
higher odds of having prolonged delay. This could be 
explained by the financial challenges the unemployed 
people go through to transport themselves to the diag-
nostic health facilities and later on pay for their care.
Lack of knowledge was a big predictor of prolonged 
delay. Our findings are similar to those in the study 
done in Kampala, Mukono and Wakiso [3, 4] where 
education was found to be a predictor of delay. Lack 
of information on TB has been found to be associated 
with delay in studies done elsewhere in East Africa [15].
As in previous studies [10, 16], there was a strong 
relation between having a second consultation and 
total delay similar to our results after bivariate analysis, 
which was not the case at multivariate analysis. Prior 
attendance to a clinic or second consultation was also 
Unemployed (student, unemployed/housewife), employed (technical/professional, peasant), unmarried (single, divorced, separated, widower)
** Statistically significant at 0.05 level
Table 2 (continued)
Factors associated with prolonged delay




 Sputum examination 52 (89.7) 6 (10.3)
 Xray 14 (82.4) 3 (17.6)
 Both sputum and Xray 39 (73.6) 14 (26.4)
 Referral 0 (0) 1 (100)
 Others 5 (100) 0 (0)
Multivariate analysis
Variable Adjusted OR (95% CI) p > |Z|
Gender
 Female 0.231 (0.080–0.670) 0.007**
Occupation
 Unemployed 3.947 (1.382–11.274) 0.010**
Marital status
 Unmarried 3.364 (0.871–13.001) 0.079
Second health facility consulted
 Private 0.632 (0.177–2.254) 0.479
Knowledge on TB
 No knowledge 6.904 (1.648–28.921) 0.04**
Action taken
 Xray and sputum 2.412 (0.904–6.433) 0.904
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found to be a predictor of delay in a study done in Ethi-
opia [17].
Over half, 79 (58.7%) of the clients were started on TB 
treatment a day or more after diagnosis. The policy rec-
ommended by the World Health Organization is that 
treatment be initiated on the same day that the diagnosis 
is made [18]. Doing this would help cut the cycle of infec-
tion and also ensure the initial default rates are reduced 
as some patients might not return to start treatment.
Limitation
Recall bias during the interviews was a limitation. We 
allowed enough time for careful probing and used avail-
able records for missing information. Also referral pat-
terns of the patients were not ascertained i.e. how many 
of the patients were referred by the lower health facilities 
and how many were self-referred.
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